Clinical Trials
2 trialsNCT04450836 2025-03-30
SOREGATT
UNICANCER
Phase 2 Terminated
NCT04854434 2023-11-03
A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Karyopharm Therapeutics Inc
Phase 2 Terminated